JenaValve Gets $26.5M for Aorta Repair Device

Irvine-based JenaValve Technology, which is developing transcatheter aortic valve repair (TAVR) systems for the treatment of aortic valve disease, said this morning that it has raised $26.5M in a Series C funding round. The funding was led by RMM (Rudi Marien) and Valiance, and also included Atlas Venture, Edmond de Rothschild Investment Partners, Gimv, Legend Capital, NeoMed Management and VI Partners. The company said the new funds goes towards its growth efforts. JenaValve is led by Victoria E. Carr-Brendel, Ph.D. More information »